Iraq vs Syria: Cause of death, by non-communicable diseases, ages 5-14, female
Iraq
37.5%
in 2021
Syria
38.2%
in 2021
Iraq rank
100th
Syria rank
97th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Iraq
- Syria
How they compare
Syria currently reports 38.2% against 37.5% in Iraq, a difference of 0.7%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Syria ahead.
Iraq ranks 100th and Syria ranks 97th of 184 countries.
Across the 3 decades both report, Iraq averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Iraq | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.8% | 52.5% | 16.7% | Syria |
| 2010s | 28.1% | 26.5% | 1.6% | Iraq |
| 2020s | 37.5% | 34.8% | 2.7% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Iraq or Syria?
- Syria, at 38.2% against 37.5% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Iraq and Syria?
- 0.7%, with Syria ahead.
- How many years of comparable data are there for Iraq and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Iraq and Syria rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Iraq ranks 100th and Syria ranks 97th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.